Sponsor content
73 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled pen.
-
OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled syringe with safety guard (520873)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab 300 mg/ 2 mL solution for injection pre-filled syringe with safety guard. -
Prescription medicine registrationActive ingredients: Aflibercept.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 45 mg/0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 90 mg/1 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 45 mg/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection pre-filled pen.
-
Australian Public Assessment Report (AusPAR)Steqeyma (ustekinumab) has been approved to treat moderate to severe plaque psoriasis, active psoriatic arthritis, crohn's disease, and ulcerative colitis.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe.